These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 8077398)
21. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Hammers-Berggren S; Hansen K; Lebech AM; Karlsson M Neurology; 1993 Jan; 43(1):169-75. PubMed ID: 8423881 [TBL] [Abstract][Full Text] [Related]
22. Comparison of four different serological methods for detection of antibodies to Borrelia burgdorferi in erythema migrans. Olsson I; von Stedingk LV; Hanson HS; von Stedingk M; Asbrink E; Hovmark A Acta Derm Venereol; 1991; 71(2):127-33. PubMed ID: 1675520 [TBL] [Abstract][Full Text] [Related]
23. Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Horowitz HW; Pavia CS; Bittker S; Forseter G; Cooper D; Nadelman RB; Byrne D; Johnson RC; Wormser GP Clin Diagn Lab Immunol; 1994 Jul; 1(4):373-8. PubMed ID: 8556471 [TBL] [Abstract][Full Text] [Related]
24. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. Engstrom SM; Shoop E; Johnson RC J Clin Microbiol; 1995 Feb; 33(2):419-27. PubMed ID: 7714202 [TBL] [Abstract][Full Text] [Related]
25. Immune complexes in early Lyme disease. Lencáková D; Stefancíková A; Ivanová R; Petko B Can J Microbiol; 2007 Dec; 53(12):1375-7. PubMed ID: 18059570 [TBL] [Abstract][Full Text] [Related]
26. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000-2005]. Czupryna P; Kuśmierczyk J; Zajkowska JM; Ciemerych M; Kondrusik M; Ciemerych A; Pancewicz SA Pol Merkur Lekarski; 2007 Aug; 23(134):103-6. PubMed ID: 18044338 [TBL] [Abstract][Full Text] [Related]
27. Intrathecal synthesis of anti-Borrelia burgdorferi antibodies in neuroborreliosis: a study with special emphasis on oligoclonal IgM antibody bands. Wang ZY; Hansen K; Sidén A; Cruz M Scand J Immunol; 1993 Mar; 37(3):369-76. PubMed ID: 8441923 [TBL] [Abstract][Full Text] [Related]
28. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. Mathiesen MJ; Christiansen M; Hansen K; Holm A; Asbrink E; Theisen M J Clin Microbiol; 1998 Dec; 36(12):3474-9. PubMed ID: 9817857 [TBL] [Abstract][Full Text] [Related]
29. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063 [TBL] [Abstract][Full Text] [Related]
31. Utilization of serology for the diagnosis of suspected Lyme borreliosis in Denmark: survey of patients seen in general practice. Dessau RB; Bangsborg JM; Ejlertsen T; Skarphedinsson S; Schønheyder HC BMC Infect Dis; 2010 Nov; 10():317. PubMed ID: 21040576 [TBL] [Abstract][Full Text] [Related]
32. The outcome of Lyme borreliosis in children. Aberer E; Kehldorfer M; Binder B; Schauperi H Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805 [TBL] [Abstract][Full Text] [Related]
33. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans. Mitchell PD; Reed KD; Aspeslet TL; Vandermause MF; Melski JW J Clin Microbiol; 1994 Aug; 32(8):1958-62. PubMed ID: 7989549 [TBL] [Abstract][Full Text] [Related]
34. Antibodies to Borrelia burgdorferi in patients with carpal tunnel syndrome. Kindstrand E Acta Neurol Scand; 1992 Jul; 86(1):73-5. PubMed ID: 1519478 [TBL] [Abstract][Full Text] [Related]
35. [Western-blot with VLSE protein and "in vivo" antigens in Lyme borreliosis diagnosis]. Zajkowska J; Kondrusik M; Pancewicz S; Grygorczuk S; Swierzbińska R; Hermanowska-Szpakowicz T; Czeczuga A; Sienkiewicz I Przegl Epidemiol; 2006; 60 Suppl 1():177-85. PubMed ID: 16909799 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic and biological significance of anti-p41 IgM antibodies against Borrelia burgdorferi. Ulvestad E; Kanestrøm A; Sønsteby LJ; Jureen R; Omland T; Edvardsen B; Lundervik J; Kristoffersen E; van Dam AP Scand J Immunol; 2001 Apr; 53(4):416-21. PubMed ID: 11285123 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Lebech AM; Hansen K; Brandrup F; Clemmensen O; Halkier-Sørensen L Mol Diagn; 2000 Jun; 5(2):139-50. PubMed ID: 11066015 [TBL] [Abstract][Full Text] [Related]
38. Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis. Cerar T; Ruzic-Sabljic E; Cimperman J; Strle F Wien Klin Wochenschr; 2006 Nov; 118(21-22):686-90. PubMed ID: 17160608 [TBL] [Abstract][Full Text] [Related]
39. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans. Olsson I; Asbrink E; von Stedingk M; von Stedingk LV Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871 [TBL] [Abstract][Full Text] [Related]
40. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans. Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]